Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.294
+0.005 (1.70%)
Mar 9, 2026, 2:05 PM EDT - Market open
Plus Therapeutics Employees
Plus Therapeutics had 21 employees as of December 31, 2024. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
$250,381
Profits / Employee
-$979,810
Market Cap
51.94M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 102 |
| Acrivon Therapeutics | 78 |
| Kezar Life Sciences | 55 |
| LeonaBio | 26 |
| MiNK Therapeutics | 23 |
| Edesa Biotech | 17 |
| Nutriband | 13 |
| Alterity Therapeutics | 9 |
PSTV News
- 12 days ago - Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ™ - GlobeNewsWire
- 6 weeks ago - Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript - Seeking Alpha
- 6 weeks ago - Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET - GlobeNewsWire
- 7 weeks ago - Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges - Benzinga
- 7 weeks ago - Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering - GlobeNewsWire
- 2 months ago - Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases - GlobeNewsWire
- 3 months ago - Plus Therapeutics Expands CNSide Assay Platform to State of California - GlobeNewsWire
- 3 months ago - Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants - GlobeNewsWire